ABCA1 and Alzheimer disease: ATP-binding cassette transporter A1 (ABCA1) levels are decreased when miR-33 is upregulated in AD; this enzyme regulates Apolipoprotein E (APOE) lipidation and Aβ metabolism, thereby increasing Aβ levels.